The Exploration of Psycholeptics Using in Intellectual Disability

• Main Authors: Gang-Zhun Zhang, 張剛準
• Other Authors: Shang-Wei Hsu
• Format: Others
• Language: zh-TW
• Published: 2011
• Online Access: http://ndltd.ncl.edu.tw/handle/08802031009803036631

碩士 === 亞洲大學 === 健康管理研究所 === 99 === Purpose: Mental illness is one of the most common complications among the intellectual disability that needs stabilize the treatment through medication. However, the domestic researches on this subject are quite few. This research is to explore the use of antipsychotics by the intellectual disability and conduct a further research on the health care usage and resource allocations for the disadvantaged groups. Methodology: Using 2004 to 2007 National Health Insurance Research Database, people with ICD-9 codes 317-319 were selected as the intellectual disability. Subjects who use ATC N05A medicine were screened to analyze outpatient health care utilization. Results: From 2004 to 2007, the prevalence rates of using antipsychotics by the intellectual disabled was 14.0~17.3 % in which the female’s 14.8~18.0% is higher than the male’s 13.5~16.7%. In term of medical treatment site, the regional hospitals account for the largest part of sites with 42.1~45.5% while urban areas account for the largest part of locations of hospital with 66.6~70.4%. On medical consumption, the gender difference only not appears in the medicine cost. As to the of days of medicine prescription, the male have 15.3 days more than the female and the differences of degree of disability, copayment and insurance areas will affect the cost of medicine and the number of days of administration. After logistic regression, we found that there were differences with the different personal characteristics and medical treatment sites and the factor of medical treatment sites had greater effects than the factor of personal characteristics. Conclusions: In this research, we had preliminary study of medication of antipsychotics by the intellectual disabled to clarify the effects of personal characteristics and medical treatment site on the differences of medication of antipsychotics. On the part of medical resource allocations, we recommend that the authorities pay more attention to the availability of medical treatment for the intellectual disabled in countryside and remote areas to enhance their medical welfares. In addition, we also recommend that the follow-up researchers conduct further exploration into the effects of long-term medication or association with other diseases by the intellectual disabled on medication consumption.